EXAS vs MIAX · rev $2.76B vs P/E 30, rev $1.36B
EXACT Sciences Corporation (EXAS) versus Miami International Holdings, Inc. (MIAX) — a side-by-side from cached financials, not a winner call.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
Miami International Holdings, Inc. (MIAX) is a capital markets company listed on NYSE.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
Latest reported MIAX revenue for 2025-12-31 was $1.36B. Net income was -$70.0M. Revenue was up 19.6% from 2024-12-31 to 2025-12-31. MIAX currently screens at market cap $3.63B and trailing P/E 29.6.
EXAS currently screens at market cap $20.03B. MIAX currently screens at market cap $3.63B and trailing P/E 29.6.
Not investment advice. Open the EXAS and MIAX stock pages for the full models.
Not investment advice.